Application

15846356 · QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

Filed 2017-12-19 · Abandoned The official file ↗ · Art unit 1629 · Examiner James D Anderson Typical · CPC A61K 31/517 · Boehringer Ingelheim International GmbH · C/O VP, IP, LEGAL

Office actions

first was Final rejection

RCEs

no appeal

To first action

10.6 mo

to disposition 17.1 mo

Statutes raised

102 103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.